Ionis to present at upcoming investor conferences Feb 19, 2026 07:05AM
TD Cowen on Ionis Pharmaceuticals (IONS): 'New Launches And Key Pipeline Catalysts To Drive Upside' Dec 3, 2025 08:26AM
Ionis Pharmaceuticals (IONS) PT Raised to $99 at TD Cowen, Top Pick Oct 30, 2025 05:55AM
TD Cowen on Ionis Pharmaceuticals (IONS): 'Deep Cardio & Neuro Pipelines Set Up Continued Revs Growth' Oct 9, 2025 09:26AM
Ionis to present at upcoming investor conferences Feb 25, 2025 07:05AM
View Older Stories

Oct 8, 2024 02:42PM TD Cowen Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
Jul 23, 2024 09:10AM Ionis Pharmaceuticals (IONS) PT Raised to $59 at TD Cowen
Jun 24, 2024 02:08PM TD Cowen Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
Jun 17, 2024 04:09PM Ionis to present at TD Cowen Genetic Medicines & RNA Summit
May 16, 2024 02:28PM TD Cowen Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
Feb 28, 2024 07:05AM Ionis to present at upcoming investor conferences
Jul 5, 2023 07:05AM Ionis to present at upcoming investor conference
Feb 28, 2023 07:05AM Ionis to present at upcoming investor conferences
Jan 9, 2023 09:15AM Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial Readiness
Jan 9, 2023 09:15AM Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial Readiness
Jan 9, 2023 09:06AM Ionis Pharmaceuticals (IONS), Royalty Pharma (RPRX) enter into royalty agreement for up to $1.1 billion
Jan 9, 2023 09:05AM Ionis and Royalty Pharma enter into royalty agreement for up to $1.1 billion to further advance Ionis' genetic medicines and commercial readiness
Mar 1, 2022 07:05AM Ionis to present at the Cowen Annual Health Care Conference
Dec 15, 2020 05:31AM Cowen Upgrades Ionis Pharmaceuticals (IONS) to Outperform
Oct 12, 2020 09:00AM Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics
Aug 31, 2020 07:21AM Ionis Pharmaceuticals (IONS) to acquire remaining stake in Akcea Therapeutics (AKCA) for $18.15/sh
Aug 31, 2020 06:55AM Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics
Feb 27, 2020 07:05AM Ionis Pharmaceuticals to present at upcoming investor conferences
Feb 26, 2020 07:00AM Akcea Therapeutics to Present at the Cowen 40th Annual Health Care Conference
Feb 26, 2020 07:00AM Akcea Therapeutics to Present at the Cowen 40th Annual Health Care Conference
Mar 7, 2019 07:05AM Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
Sep 24, 2018 04:11PM Ionis Pharmaceuticals (IONS) Announces Dr. Michael Hayden & Peter N. Reikes to Board
Sep 24, 2018 04:06PM Ionis Announces the Appointment of Two New Board Members
Apr 17, 2018 09:00AM Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR
Apr 17, 2018 09:00AM Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR
Apr 17, 2018 09:00AM Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR
Mar 15, 2018 06:57AM Ionis Pharma (IONS), Akcea Therapeutics (AKCA) Partner on Inotersen for hATTR; $150M Upfront to Ionis Paid in Stock
Mar 15, 2018 06:50AM Ionis and Akcea Partner to Commercialize Inotersen for hATTR
Mar 6, 2018 09:00AM Akcea Therapeutics to Present at Upcoming Investor Conferences
Mar 6, 2018 09:00AM Akcea Therapeutics to Present at Upcoming Investor Conferences
Mar 6, 2018 07:00AM Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
Jul 19, 2017 04:19PM Akcea Therapeutics (AKCA) Closes IPO, Reports $50M Private Placement with Novartis Pharma (NVS)
Jul 19, 2017 04:15PM Akcea Therapeutics Announces Closing of Initial Public Offering
Jul 13, 2017 08:25PM Akcea Therapeutics Announces Pricing of Initial Public Offering
Jun 20, 2017 07:03AM Akcea Therapeutics (AKCA) Launches Proposed IPO with Initial Offering Price of $12 to $14/Share (IONS)
Jun 20, 2017 07:00AM Akcea Therapeutics Launches Proposed Initial Public Offering
May 15, 2017 04:40PM Cowen Reiterates Outperform Rating and $100 PT on Alnylam Pharma (ALNY); 'Ionis Pharma (IONS) Data Show Efficacy in FAP Bodes Well for Ph3 APOLLO in Sept.'
Mar 27, 2017 06:53AM Ionis Pharma (IONS) Spinoff Akcea Therapeutics (AKCA) Files IPO
Mar 27, 2017 06:48AM Akcea Therapeutics Files Registration Statement for Proposed Initial Public Offering
Feb 1, 2017 07:00AM Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 3, 2016 10:41AM Notable Analyst Rating Changes 8/3: (ZNGA) (NMBL) (AVD) Upgraded; (CSIQ) (EQR) (EMR) Downgraded
May 26, 2016 11:49AM Cowen Downgrades Ionis Pharmaceuticals (IONS) to Market Perform
Mar 4, 2016 07:00AM Akcea Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
Feb 24, 2016 02:50PM Trading Radar for 2/25: Baidu (BIDU), Best Buy (BBY), Sears (SHLD), Weight Watchers (WTW) Report
Feb 4, 2016 07:00AM Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
View Older Stories